{
    "2021-04-20": [
        [
            {
                "time": "2021-04-20",
                "original_text": "东吴证券----金域医学2020年年报及2021年一季报点评：业绩高增长，股权激励体现公司信心，ICL龙头发展提速【公司研究】",
                "features": {
                    "keywords": [
                        "金域医学",
                        "年报",
                        "一季报",
                        "业绩高增长",
                        "股权激励",
                        "ICL龙头"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-04-20",
                "original_text": "一季度多只医药股获明星基金增持",
                "features": {
                    "keywords": [
                        "医药股",
                        "明星基金",
                        "增持"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-20",
                "original_text": "医疗板块持续拉升，凯普生物一季报利润暴涨8倍涨超7.6%",
                "features": {
                    "keywords": [
                        "医疗板块",
                        "凯普生物",
                        "一季报",
                        "利润暴涨"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-20",
                "original_text": "高瓴资本概念股普遍强势，甘李、泰格、金域、国瓷材料、健帆生物大涨",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "概念股",
                        "金域医学",
                        "大涨"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-20",
                "original_text": "金域医学去年净利15亿销售费近10亿 一季度两基金减仓",
                "features": {
                    "keywords": [
                        "金域医学",
                        "净利",
                        "销售费",
                        "基金减仓"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-04-20",
                "original_text": "受益于新冠业务收入增长，金域医学一季度业绩大增超10倍",
                "features": {
                    "keywords": [
                        "金域医学",
                        "新冠业务",
                        "业绩大增"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}